Great Lakes Advisors LLC boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 113.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 206,381 shares of the company’s stock after buying an additional 109,595 shares during the period. Great Lakes Advisors LLC owned approximately 0.10% of Bath & Body Works worth $5,316,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the business. JPMorgan Chase & Co. boosted its position in shares of Bath & Body Works by 11.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock valued at $212,120,000 after acquiring an additional 733,000 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Bath & Body Works by 5.8% during the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock valued at $171,904,000 after buying an additional 315,738 shares in the last quarter. Cooper Creek Partners Management LLC grew its holdings in shares of Bath & Body Works by 42.7% during the second quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock valued at $162,081,000 after buying an additional 1,619,276 shares during the last quarter. AQR Capital Management LLC raised its holdings in Bath & Body Works by 5.3% in the 2nd quarter. AQR Capital Management LLC now owns 4,203,326 shares of the company’s stock worth $125,322,000 after acquiring an additional 210,153 shares during the last quarter. Finally, GMT Capital Corp boosted its position in Bath & Body Works by 8.8% in the second quarter. GMT Capital Corp now owns 4,067,000 shares of the company’s stock worth $121,847,000 after purchasing an additional 329,300 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.
Bath & Body Works Stock Up 5.1%
BBWI stock opened at $21.79 on Friday. The stock has a market cap of $4.46 billion, a price-to-earnings ratio of 6.70, a PEG ratio of 0.75 and a beta of 1.51. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $41.87. The business has a 50 day moving average price of $20.39 and a 200 day moving average price of $24.77.
Bath & Body Works Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Friday, November 21st were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.7%. The ex-dividend date was Friday, November 21st. Bath & Body Works’s dividend payout ratio is presently 24.62%.
Insider Activity
In other Bath & Body Works news, Director Stephen D. Steinour acquired 6,700 shares of the stock in a transaction dated Friday, November 21st. The stock was acquired at an average price of $14.86 per share, with a total value of $99,562.00. Following the completion of the transaction, the director directly owned 48,175 shares in the company, valued at approximately $715,880.50. This trade represents a 16.15% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Lucy Brady acquired 3,470 shares of the business’s stock in a transaction dated Friday, November 21st. The shares were bought at an average price of $14.40 per share, for a total transaction of $49,968.00. Following the completion of the acquisition, the director owned 17,482 shares in the company, valued at approximately $251,740.80. This trade represents a 24.76% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders acquired 33,513 shares of company stock worth $500,442. Corporate insiders own 0.26% of the company’s stock.
Bath & Body Works News Summary
Here are the key news stories impacting Bath & Body Works this week:
- Neutral Sentiment: Context on recent operating results and analyst commentary — a recent industry roundup revisits Bath & Body Works’ Q3 earnings and may inform investor views on fundamentals rather than litigation. Reflecting on beauty and cosmetics retailer stocks’ Q3 earnings: Bath and Body Works (NYSE:BBWI)
- Negative Sentiment: Multiple securities class actions filed / law firms soliciting plaintiffs — firms (e.g., Gainey McKenna & Egleston, Kessler Topaz, Glancy Prongay Wolke & Rotter and others) say suits were filed on behalf of investors who bought BBWI between June 4, 2024 and Nov 19, 2025, alleging material misstatements/omissions tied to a sharp Nov. 19 share drop. These notices increase litigation risk and could lead to settlements, higher legal costs, management distraction and investor uncertainty. Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bath & Body Works, Inc. (BBWI) Kessler Topaz Meltzer & Check, LLP Encourages Bath & Body Works, Inc. Investors with Losses to Contact the Firm Deadline Alert: Glancy Prongay Wolke & Rotter LLP
- Negative Sentiment: Deadlines and scale — several firms cite lead?plaintiff filing deadlines in mid?March (March 13–16, 2026). The breadth of solicitations (many firms contacting investors) suggests sustained media/legal attention, which can prolong volatility and keep a risk premium on the shares until claims are resolved or dismissed. Faruqi & Faruqi, LLP Investigates Claims
Wall Street Analysts Forecast Growth
BBWI has been the topic of several research analyst reports. Telsey Advisory Group downgraded Bath & Body Works from an “outperform” rating to a “market perform” rating and lowered their price objective for the company from $38.00 to $17.00 in a research report on Friday, November 21st. Bank of America reduced their price objective on shares of Bath & Body Works from $40.00 to $32.00 and set a “buy” rating for the company in a research note on Thursday, November 20th. Robert W. Baird set a $20.00 target price on shares of Bath & Body Works in a research report on Wednesday, December 17th. Morgan Stanley reiterated an “equal weight” rating and issued a $18.00 price objective (down from $43.00) on shares of Bath & Body Works in a report on Friday, November 21st. Finally, Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, November 12th. Five investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $23.53.
View Our Latest Stock Report on Bath & Body Works
Bath & Body Works Company Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Featured Articles
- Five stocks we like better than Bath & Body Works
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
